# Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001

> **NCT00636090** · — · COMPLETED · sponsor: **Duke University** · enrollment: 35 (actual)

## Conditions studied

- Metastatic Hormone Refractory Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00636090
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-12
- **Final completion:** 2010-01
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2013-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00636090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00636090, "Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00636090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*